Related by context. All words. (Click for frequent words.) 70 variance ANOVA 67 pairwise comparisons 67 Univariate 66 univariate 66 multivariate logistic regression 66 multiple logistic regression 66 interobserver 66 Poisson regression 65 logistic regression 65 bivariate 65 logistic regression model 65 ANCOVA 64 conditional logistic regression 64 ANOVA 64 logistic regression analyzes 64 posttreatment 64 logistic regression analysis 64 multivariate regression 64 multiple linear regression 64 F FDG PET 63 Histologic 63 nonparametric 63 multivariate analyzes 63 covariate 63 MDRD 63 Bonferroni 63 interobserver reliability 63 Multivariate 62 generalized estimating 62 estimated GFR 62 multivariate Cox 62 chi squared 62 univariate analyzes 62 multivariable logistic regression 62 multivariable Cox 62 pharmacodynamic parameters 62 regression coefficients 62 logistic regression models 62 genotypic resistance 61 Histopathologic 61 Kruskal Wallis test 61 Genotypic 61 Multivariate logistic regression 61 Pharmacodynamic 61 meta analytic 61 metabolite concentrations 61 Mantel Haenszel 61 confidence intervals CIs 61 binary logistic regression 61 Pharmacokinetic 61 Logistic regression 61 HOMA IR 61 categorical variables 60 covariance 60 multivariable analysis 60 ROC curves 60 univariate analysis 60 Pharmacokinetic PK 60 bivariate analysis 60 unpaired t 60 generalized linear 60 Descriptive statistics 60 virological response 60 Kaplan Meier curves 59 ADAS cog 59 meta regression 59 multivariate regression analysis 59 Bonferroni correction 59 Multiple logistic regression 59 electrophysiologic 59 myocardial viability 59 arterial elasticity 59 serum cortisol 59 ROC curve 59 bivariate analyzes 59 Index CDAI 59 postintervention 59 corrected QT interval 59 atheroma volume 59 PSA kinetics 59 Crohn Disease Activity 59 Hemodynamic 59 Kaplan Meier method 59 posttest 59 correlation coefficients 59 Pearson correlation coefficient 59 intraobserver 59 Kaplan Meier analysis 59 urodynamic 59 χ 59 Alzheimer Disease Assessment 59 HER2 expression 59 differential gene expression 59 Clinical Relevance 59 multivariable analyzes 59 histopathological 59 dosimetric 59 Kaplan Meier 59 SUVmax 59 mammographic density 58 cortical activation 58 F FDG uptake 58 HRCT 58 Kaplan Meier survival 58 intact parathyroid hormone 58 Patency 58 Pharmacokinetic parameters 58 induced sputum 58 MMSE score 58 Rating Scale BPRS 58 metabolic parameters 58 allele frequencies 58 carotid IMT 58 Morphological 58 YMRS 58 Double Blind Randomized 58 hematologic parameters 58 β blockers 58 Score IPSS 58 Echocardiographic 58 femoral neck BMD 58 laterality 58 FDG-PET/CT 58 Multivariate analysis 58 Meta analyzes 58 interobserver agreement 58 RQ PCR 58 ß = 58 Wilcoxon rank sum 58 #F FDG PET 58 sensitivity specificity 58 albumin excretion rate 58 regression equations 58 immunohistochemical 58 TNSS 58 Multiple linear regression 58 logistic regressions 57 transient elastography 57 WOMAC pain 57 Hemoglobin A1c 57 tumor perfusion 57 Multivariable 57 FDG PET CT 57 HIV RNA 57 -#.# ± [002] 57 serum HBV DNA 57 spirometric 57 IGRAs 57 exploratory endpoints 57 Main Outcome Measures 57 ^ sup #m 57 NIHSS score 57 radiation dosimetry 57 intima media thickness 57 CIN2 + 57 serum PSA 57 WAIS III 57 Prospective Randomized Trial 57 Linear regression 57 p = #.# [003] 57 Virologic Response 57 hemodynamic parameters 57 RT qPCR 57 Electrodiagnostic 57 semiquantitative 57 TRUS 57 Visual Analogue Scale VAS 57 preoperative PSA 57 μmol L 57 HCT# 57 subanalysis 57 endometrial thickness 57 NIH CPSI 57 Tumor Response 57 HAQ DI 57 Histological 57 neurocognitive function 57 dose proportionality 57 Pearson correlation coefficients 57 #OHD 57 leukocyte counts 57 periprocedural 57 Preoperative 57 Subgroup analysis 57 dyssynchrony 57 serum estradiol 57 ± SEM 57 secondary efficacy endpoint 57 platelet reactivity 57 lumbar spine BMD 57 CHADS2 57 histological subtype 57 International Prostate Symptom 57 immunohistochemical analysis 56 p = NS 56 adenoma detection 56 QTc 56 interrater reliability 56 Angiographic 56 atorvastatin #mg 56 plasma cortisol 56 oncologic outcomes 56 Gastrointestinal Stromal Tumors 56 Bioavailability 56 prognostic variables 56 quantitative EEG 56 odds ratios ORs 56 TPV r 56 eNO 56 Insulin Delivery Systems 56 mg BID dose 56 adenoma recurrence 56 Preoperatively 56 leukocyte count 56 microsatellite instability 56 pharmacokinetic PK profile 56 corneal thickness 56 pulmonary arterial 56 Cardiotoxicity 56 creatinine ratio 56 Quantification 56 cytologic 56 immunostaining 56 subscores 56 OGTT 56 histopathologic findings 56 multivariable adjusted 56 hemodynamic variables 56 microvessel density 56 UPDRS 56 CORE OM 56 p = .# [002] 56 statistical significance p 56 plasma lipid 56 logit 56 Physiologic 56 QEEG 56 salivary cortisol 56 NHANES III 56 Clinical Outcome 56 morphometric vertebral fractures 56 abdominal adiposity 56 Pegylated Liposomal Doxorubicin 56 covariates 56 unfractionated heparin UFH 56 regression analyzes 56 scintigraphic 56 RE LY trial 56 inhibin B 56 cardiac magnetic resonance 56 XIENCE V PROMUS Stent 56 myocardial uptake 56 Lp PLA 2 56 bivalirudin monotherapy 56 Immunohistochemical 56 anti JCV antibodies 56 hemoglobin Hb 56 serum urate levels 56 prostate cancer CaP 56 biochemical recurrence 56 regression coefficient 56 Pain Intensity 56 NMIBC 56 metaanalysis 55 Brief Psychiatric 55 multivariable 55 EBMT criteria 55 chromatograms 55 Intermountain Risk Score 55 nausea photophobia 55 virologic response 55 baseline LDH 55 malignant nodules 55 serum creatinine levels 55 r2 = 55 LOCF 55 Capacity FVC 55 fluorescence intensity 55 Non inferiority 55 thickness IMT 55 prespecified secondary 55 transvaginal sonography 55 ABL1 55 mRNA expression 55 heterozygotes 55 Radiographic 55 Protelos R 55 linear regression models 55 transcranial Doppler 55 Coronary CTA 55 plasma pharmacokinetics 55 Ocular Surface Disease 55 stepwise logistic regression 55 cytoreductive nephrectomy 55 Prognostic Value 55 Cronbach alpha 55 DCE MRI 55 STN stimulation 55 Univariate analysis 55 diffusion tensor 55 QTcF 55 ultrasonographic 55 electrocardiographic 55 subscale scores 55 attain statistical significance 55 affective psychosis 55 serum urate 55 biopsied tissue 55 null hypothesis 55 Postoperative 55 genotypic 55 IFN α 55 inflammatory biomarkers 55 Kaplan Meier curve 55 mean ± SEM 55 dimensional echocardiography 55 serum biomarkers 55 FDG uptake 55 tumor histology 55 APOE genotype 55 serum retinol 55 p# biomarker 55 achieved statistical significance 55 Reproducibility 55 antimicrobial susceptibility 55 CFQ R 55 Mutational 55 ertapenem 55 retest reliability 55 diffusivity 55 carotid intima media 55 urine cytology 55 ALT elevation 55 Glomerular filtration rate 55 Crystallographic 55 clinicopathological 55 PSA nadir 55 Alkaline Phosphatase 55 HbA 1c levels 55 intraclass correlation coefficients 55 Repeatability 55 transcranial Doppler ultrasound 55 nonrandomized 55 Pharmacodynamics 55 SpO 2 55 BRCA2 mutation carriers 55 Electrophysiological 55 HAM D# 55 RT PCR assay 55 6MWD 55 Hb A1C 55 Bioequivalence 55 fructosamine 55 PIB PET 55 qRT PCR 55 doxorubicin docetaxel 55 inter rater reliability 55 pulp metallic 55 serum homocysteine 55 recursive partitioning 55 epoetin alpha 55 thyroglobulin 55 ARB telmisartan 55 NIHSS 55 CI -#.# 55 transfection efficiency 55 transabdominal 55 tertiles 55 premorbid 54 Ejection Fraction 54 ADAS Cog 54 linear regression analysis 54 Subscale 54 VKORC1 54 coronary stenosis 54 carotid artery thickness 54 serum prostate 54 axial length 54 subscore 54 MERIT ES 54 baseline FEV 54 bronchoalveolar lavage 54 Titration 54 postop 54 VADT 54 colorectal adenoma 54 Mammographic 54 clinicopathological features 54 Fig. 3b 54 calculated creatinine clearance 54 hematological parameters 54 ABC/3TC 54 virologic 54 differentially expressed genes 54 Comorbidity 54 interrater 54 CYP#C# gene 54 ADCS ADL 54 microg 54 EQ 5D 54 κ 54 genomewide 54 prospectively defined 54 TIMP 1 54 MMSE 54 pharmacodynamic markers 54 multivariable regression 54 serum lipid 54 nomogram 54 HDRS 54 elastic modulus 54 plasma renin 54 morphologic 54 serum testosterone 54 cerebral oxygen saturation 54 NAMCS 54 T2 lesions 54 Supplementary Table 54 Logistic Regression 54 Cytogenetic 54 Fulvestrant 54 Viral load 54 -#.# log# 54 tissue oxygenation 54 intratumoral 54 morphometric 54 Phenotypic 54 STEP BD 54 STRIDE PD 54 virologic responses 54 echocardiographic 54 serum TSH 54 specific antigen PSA 54 extrapyramidal symptoms 54 TURBT 54 TPMT 54 serum calcium 54 Visual Analog 54 AUA Symptom Score 54 echocardiographic parameters 54 nomograms 54 FDG PET imaging 54 timepoints 54 arteriolar 54 transgene expression 54 statistically significant p = 54 fluorodeoxyglucose positron emission tomography 54 explanatory variables 54 anterior posterior 54 LPV r 54 definite stent thrombosis 54 CDAI score 54 rearfoot 54 inotropic 54 serum PTH 54 #β estradiol 54 Randomized controlled 54 parasitaemia 54 contrast echocardiography 54 EuroSCORE 54 radioligand 54 homocysteine concentrations 54 cTnT 54 digital subtraction angiography 54 peritumoral 54 Annexin V 54 postoperative mortality 54 RE LY ® 54 glomerular filtration rate 54 hepatic fibrosis 54 postoperative complication 54 Immunohistochemical analysis 54 Randomized trials 54 endoscopic ultrasonography 54 Rating Scale MADRS 54 multivariate statistical 54 Taxus Stent 54 glycosylated hemoglobin HbA1c 54 Symptom Checklist 54 primary aldosteronism 54 Severity MSCS score 54 Logistic regression analysis 54 interindividual variability 54 histopathologic 54 FDG PET 54 detrusor 54 oxycodone CR 54 autocorrelation 54 cystoscopic 54 QTc prolongation 54 intima media thickness IMT 54 etiologic 54 convergent validity 54 gadolinium enhancing 54 glutamate glutamine 54 prospective multicentre 54 Kruskal Wallis 54 postprocedure 54 Young modulus 54 Blood Pressure Lowering 54 hepatic lesions 54 confounding variables 54 dose atorvastatin 54 MR spectroscopy 54 clinically meaningful improvement 54 P = .# 54 NPH insulin 54 Neuropsychiatric Inventory 53 locomotor activity 53 conventional angiography 53 quantile 53 TNFalpha 53 immunoreactivity 53 FDA defined valvulopathy 53 aberrometer 53 d dimer 53 Major Adverse Cardiac 53 viral kinetics 53 rCBF 53 intraclass correlation coefficient 53 Comparators 53 RECIST Response Evaluation Criteria 53 Randomised 53 trials RCTs 53 Assessment Questionnaire 53 Scale cognitive subscale 53 hip BMD 53 cTnT levels 53 Montgomery Åsberg Depression 53 ER CHOP 53 peak VO2 53 desvenlafaxine succinate 53 #:#-# [029] 53 Solid Tumours 53 Kaplan Meier estimates 53 platelet inhibition 53 preoperatively 53 mL/min/#.# m 2 53 clinico pathological 53 renal cortical 53 miRview squamous 53 chemoradiation therapy 53 Dyslipidemia 53 histopathologic examination 53 allelic 53 hematological relapse 53 Secondary efficacy endpoints 53 Pathologic 53 Dose Response 53 Cystatin C 53 WOMAC scores 53 gadolinium enhanced 53 SVR# 53 plasma homocysteine 53 relapsed MM 53 transthoracic 53 paricalcitol 53 biochemical relapse 53 MoxDuo TM IR 53 T1 weighted images 53 PSADT 53 AST ALT 53 Doppler echocardiography 53 Solubility 53 Figure 1A 53 hierarchical clustering 53 BCR ABL mutations 53 SerDes transceivers 53 lispro 53 Randomized Evaluation 53 lumbar spine bone 53 D dimer 53 FACIT 53 Prostate Cancer Progression 53 multivariate adjustment 53 lymphovascular invasion 53 morphologic characteristics 53 spectrophotometric 53 quantitative PCR 53 antioxidant supplementation 53 serum concentrations 53 rs# [004] 53 corneal staining 53 CR nPR 53 Subgroup analyzes 53 florbetaben 53 eplerenone 53 COMT genotype 53 Leydig cell 53 activated partial thromboplastin 53 linkage disequilibrium 53 linearized 53 Symptom Severity 53 Digit Symbol Substitution 53 sociodemographic factors 53 KRAS mutation 53 Bivalirudin 53 chest radiographs 53 distensibility 53 dichotomous variables 53 histologic findings 53 nitrotyrosine 53 RRM1 53 serum phosphorous 53 Unfractionated Heparin 53 serum IgG 53 Virologic 53 TT genotype 53 Sipuleucel T 53 LC MALDI 53 MDRD equation 53 proximal femur 53 interquartile range IQR 53 apparent diffusion coefficient 53 corneal curvature 53 Aspergillus nidulans 53 periprocedural MI 53 hippocampal volume 53 tipranavir r 53 serum clusterin levels 53 intraventricular 53 lactate dehydrogenase 53 X ray absorption spectroscopy 53 helical CT 53 aPTT 53 pT3 53 Eur Urol 53 kidney allograft 53 Confidence Intervals 53 urine albumin 53 extensive metabolizers 53 noninferior 53 serum magnesium 53 variant allele 53 Myocardial Perfusion Imaging 53 TOP2A 53 HAMD 53 Post hoc 53 creatinine clearance 53 dehydroepiandrosterone sulfate 53 residual confounding 53 myocardial reperfusion 53 thickness CIMT 53 androgen suppression 53 SABCS 53 #S rRNA gene 53 neutropaenia 53 warfarin dosage 53 adenotonsillectomy 53 SF #v# 53 mediated dilation 53 postoperative hemorrhage 53 tPSA 53 Finite element 53 histopathologic diagnosis 53 baseline HbA1c 53 serum BDNF 53 Montgomery Asberg Depression 53 Quantitative PCR 53 Visual acuity 53 core needle biopsies 53 accelerometry 53 electroencephalographic 53 calorimetric 53 Cholinesterase Inhibitors 53 Hematologic 53 mRS 53 Variability 53 myocardial necrosis 53 Heart Rate Variability 53 QTLs 53 Supplementary Figs 53 linear regression analyzes 53 Neuropsychiatric Inventory NPI 53 oxyhemoglobin 53 mg kg dose 53 Breast Density 53 prognostic indicators 53 ablative therapy 53 iPTH 53 dose Iluvien 53 fundus photography 53 postoperative radiographs 53 psychophysiological 53 ERalpha 53 morphometric analysis 53 SGRQ 53 LV ejection fraction 53 tipranavir ritonavir 53 HIV tropism 53 NSABP B 53 subgroup analyzes 53 Outcome Measures 53 randomized controlled trials RCTs 53 APACHE II 53 glycemia 53 pretest probability 53 triiodothyronine 53 CIBIC plus 53 F FLT 52 Computed tomographic 52 nonpregnant women 52 chi ^ sup 52 computed tomographic scans 52 pharmacodynamic properties 52 euthymic patients 52 Hypotension 52 perioperative complications 52 ECLS 52 carotid artery stenting CAS 52 variogram 52 Supplementary Appendix 52 serum lactate 52 prognostic significance 52 eosinophil count 52 brachial blood 52 eculizumab therapy 52 NIR spectroscopy 52 Immunomodulatory 52 vastus lateralis 52 arthrography 52 proportional hazards 52 seropositivity 52 hallux valgus 52 MSLT 52 flow cytometric 52 glaucomatous 52 log# copies mL 52 FOLPI 52 nucleotide substitutions 52 albumin excretion 52 APTIVUS r 52 Haptoglobin 52 correlational 52 Transcriptome 52 estimated glomerular filtration 52 symptomatic VTE 52 pulsed Doppler 52 Percutaneous Tibial Nerve Stimulation 52 femoral head 52 linear regressions 52 comparator PI r 52 empiric 52 intravenous thrombolysis 52 glomerular filtration 52 % Confidence Interval 52 glycated hemoglobin levels 52 procalcitonin 52 isokinetic 52 Female Sexual Function 52 NESARC 52 Spine Patient Outcomes 52 linear regression 52 EURIDIS 52 RNFL thickness 52 Observational studies 52 uM 52 Regression analyzes 52 Fibromyalgia Impact Questionnaire 52 troponins 52 urinary calcium 52 Bosentan 52 BMI z 52 Gaussian distribution 52 Digital Imaging Complexion 52 clinicopathologic 52 hsCRP levels 52 baroreflex sensitivity 52 #Gy 52 Dosages 52 EUS FNA 52 arterial thickening 52 rs# [001] 52 PREVENT IV 52 comparative genomic 52 Gram stain 52 Immunogenicity 52 hyperintensity 52 Sonographic 52 Main Outcome Measure 52 Oral Fingolimod 52 Predictive Value 52 lesional 52 prespecified 52 Creatinine 52 NRF2 gene 52 randomized blinded 52 fasting insulin 52 demyelinating 52 Primary endpoints 52 methodologic 52 Ki# 52 radical prostatectomy RP 52 pharmacodynamic effects 52 pharmacokinetic PK 52 foveal thickness 52 hypoperfusion 52 lactate dehydrogenase LDH 52 Supplemental Figure 52 % CI #.#-#.# [003] 52 cerebral oxygenation 52 binary restenosis 52 angiographic outcomes 52 HBeAg seroconversion 52 neuroanatomical 52 mitral annular 52 serologically active patients 52 KOOS 52 oxcarbazepine 52 IgG antibody 52 T2 lesion volume 52 physiologic parameters 52 gene polymorphisms 52 Imprecise 52 syndromal 52 SYNTAX 52 trough FEV1 52 IL#B 52 EBRT 52 SBM frequency 52 Insulin Glargine 52 pyridostigmine 52 bioavailable testosterone 52 TAXUS V 52 CPAP adherence 52 FOREXYARD Daily Forex 52 serum HCV RNA 52 Quantitation 52 bronchial hyperresponsiveness 52 left ventricular diastolic 52 multicentre randomized 52 echogenicity 52 bladder carcinoma 52 ± SD 52 Heterogeneity 52 Multicenter 52 Doxil ® 52 recurrent venous thromboembolism 52 pharmacokinetic characteristics 52 concomitant medications 52 Doppler sonography 52 Tasigna prolongs 52 erythrocyte sedimentation rate 52 fractional anisotropy 52 Anthropometric 52 Mitotic 52 HER2 amplification 52 antidiabetic medications 52 epicardial adipose tissue 52 pulmonary capillary wedge 52 ezetimibe simvastatin 52 Risk Stratification 52 multivariate adjusted 52 pulmonary artery catheter 52 UGT#A# 52 interstitial fluid 52 variograms 52 bisacodyl 52 PON1 gene 52 rFVIIa 52 p = .# [001] 52 DAS# CRP 52 P ≤ 52 ProfitSource 52 radiographic progression 52 Prognostic 52 PD2i R 52 Forced Vital 52 Fig. 1b 52 FEV ^ sub 52 Cardiorespiratory fitness 52 Myocardial Infarction TIMI 52 hip resurfacing arthroplasty 52 leukocytosis 52 EEG recordings 52 echo planar 52 Hemoccult II 52 percutaneous vertebroplasty 52 Estrogen Receptor 52 HPA axis suppression 52 IFN γ 52 triacylglycerol concentrations 52 endometrial carcinoma 52 lymph node metastasis 52 serum lipid levels 52 cerebral microbleeds 52 urolithiasis 52 #.#mg/dL 52 Nocturia 52 ECG gated 52 Platelet Inhibition 52 neurophysiologic 52 Sensitivity analyzes 52 Histogram 52 Correlation coefficients 52 VNTR 52 actigraphy 52 Depressive symptoms 52 serum lipids 52 TOP2A gene 52 CYP#C# [001] 52 PCWP 52 ChIP Seq 52 IVIVC 52 fasting plasma glucose FPG 52 serum triglycerides 52 Flow cytometry 52 antitrypsin 52 Child Behavior Checklist 52 HbA1C 52 tertile 52 perfusion MRI 52 PASI scores 52 serum bilirubin 52 Brief Pain 52 anti Xa 52 parameter estimation 52 Sensitivity Analysis 52 Fig. 2B 52 RNFL 52 isoenzyme 52 rho = 52 ALSFRS R 52 ischemic lesions 52 nonsignificant 52 ziprasidone 52 carotid plaque 52 TUNEL 52 prospectively stratified 52 artery occlusion 52 sociodemographic characteristics 52 Haplotype 52 renal artery stenosis 52 Analyte 52 transcriptomic 52 liver metastasis 52 composite endpoint 52 umbilical artery 52 neuroimaging studies 52 factorial 52 ‰ ¥ 52 Ecological Synthesis 52 Reproducible 52 Masimo Radical 7 52 CYP#A# inhibitors 52 kurtosis 51 titrated glipizide 51 neurodevelopmental outcome 51 physiologic responses 51 Confirmatory 51 Fig. 2a 51 QTc interval 51 thyrotropin 51 Calcium absorption 51 preintervention 51 radiotherapy RT 51 Targeted Therapy 51 neurologic progression 51 aspartate aminotransferase AST 51 PRADAXA #mg 51 Statistically Significant 51 Non Inferiority 51 Secondary endpoints 51 Regression analysis 51 stoichiometry 51 Epworth Sleepiness Scale 51 ventilation perfusion 51 Scale PANSS 51 Secondary endpoints included 51 liver histology 51 enzyme kinetics 51 primary patency 51 airway responsiveness 51 depressive symptomatology 51 tHcy 51 MADRS scores 51 Histopathological 51 alanine aminotransferase 51 multiplexing capability 51 Atrial 51 Response Evaluation Criteria 51 serum ferritin 51 urothelial carcinoma 51 Controlled Trial 51 node metastases 51 Eq. 51 symptomatology 51 subtrochanteric 51 Likert scale 51 sperm morphology 51 fasting plasma 51 Pred Forte 51 transesophageal echocardiography 51 Granger causality 51 LV dysfunction 51 cTnI 51 atherosclerotic lesion 51 Pemetrexed 51 ASCUS